Travellers’ adherence to atovaquone/proguanil malaria chemoprophylaxis after return from endemic areas
Background: According to current guidelines, atovaquone/proguanil (AP) malaria chemoprophylaxis is taken once daily during travel, and continued for seven days after return from malaria-endemic areas. However, pharmacokinetic data and studies on drug-sparing AP regimens suggest that AP could possibl...
Saved in:
Main Authors: | Jenny Lea Schnyder, David Cornelis Birkhoff, Myrthe Celine Jarings, Sabine Margot Hermans, Martin Peter Grobusch, Hanna Katrien de Jong |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Travel Medicine and Infectious Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1477893925000183 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antimalarial Combination Therapies Increase Gastric Ulcers Through an Imbalance of Basic Antioxidative‑Oxidative Enzymes in Male Wistar Rats.
by: Kalange, Muhamudu, et al.
Published: (2023) -
Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection
by: Matteo Megna, et al.
Published: (2022-07-01) -
Serological Profile of Anti-<i>Toxoplasma gondii</i> Antibodies in Liver Transplant Recipients
by: Gabriella Beltrame Pintos, et al.
Published: (2025-01-01) -
Home management of malaria among caregivers of under-five children in Owo, Ondo State, Nigeria
by: Liasu Adeagbo Ahmed, et al.
Published: (2017-11-01) -
Recent approaches in the drug research and development of novel antimalarial drugs with new targets
by: Chinnappanna Naveen Kumar Reddy, et al.
Published: (2023-03-01)